Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
A mix of the right parasitic protein with the right production method has yielded a vaccine candidate for placental malaria. Primarily affecting first-time pregnant women, placental malaria is estimated to cause 200,000 infant deaths and 10,000 maternal deaths annually. In this study, led by Benoît...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
17. July 2018
|
| In: |
npj vaccines
Year: 2018, Jahrgang: 3, Pages: 1-11 |
| ISSN: | 2059-0105 |
| DOI: | 10.1038/s41541-018-0064-6 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/s41541-018-0064-6 Verlag, Volltext: https://www.nature.com/articles/s41541-018-0064-6 
|
| Verfasserangaben: | Arnaud Chêne, Stéphane Gangnard, Célia Dechavanne, Sebastien Dechavanne, Anand Srivastava, Marilou Tétard, Sophia Hundt, Odile Leroy, Nicolas Havelange, Nicola K. Viebig, Benoît Gamain |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1663460027 | ||
| 003 | DE-627 | ||
| 005 | 20230817164628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190423s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41541-018-0064-6 |2 doi | |
| 035 | |a (DE-627)1663460027 | ||
| 035 | |a (DE-599)KXP1663460027 | ||
| 035 | |a (OCoLC)1341210141 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Chêne, Arnaud |e VerfasserIn |0 (DE-588)1149094869 |0 (DE-627)1009389300 |0 (DE-576)496560727 |4 aut | |
| 245 | 1 | 0 | |a Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development |c Arnaud Chêne, Stéphane Gangnard, Célia Dechavanne, Sebastien Dechavanne, Anand Srivastava, Marilou Tétard, Sophia Hundt, Odile Leroy, Nicolas Havelange, Nicola K. Viebig, Benoît Gamain |
| 264 | 1 | |c 17. July 2018 | |
| 300 | |b Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.04.2019 | ||
| 520 | |a A mix of the right parasitic protein with the right production method has yielded a vaccine candidate for placental malaria. Primarily affecting first-time pregnant women, placental malaria is estimated to cause 200,000 infant deaths and 10,000 maternal deaths annually. In this study, led by Benoît Gamain, researchers from France’s INSERM and Germany’s European Vaccine Initiative assayed a combination of proteins designed to target and block a key pathogenic mechanism of parasite-infected red blood cells. Finding the highest performing protein, the researchers also used an Escherichia coli expression system able to replicate and fold the complex protein correctly. During tests, this protein/vector combination bested others in production qualities and immunogenicity. The team’s efforts laid the foundations for a scalable, low-cost vaccine that is currently undergoing clinical trials. | ||
| 700 | 1 | |a Leroy, Odile |e VerfasserIn |0 (DE-588)1081792701 |0 (DE-627)846672553 |0 (DE-576)45479732X |4 aut | |
| 700 | 1 | |a Havelange, Nicolas |e VerfasserIn |0 (DE-588)1138953261 |0 (DE-627)896573524 |0 (DE-576)492795673 |4 aut | |
| 700 | 1 | |a Viebig, Nicola |e VerfasserIn |0 (DE-588)1078783403 |0 (DE-627)839454244 |0 (DE-576)451813693 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t npj vaccines |d [London] : Nature Publishing Group, 2016 |g 3(2018), Artikel-ID 28, Seite 1-11 |h Online-Ressource |w (DE-627)87811839X |w (DE-600)2882262-6 |w (DE-576)482759011 |x 2059-0105 |7 nnas |a Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development |
| 773 | 1 | 8 | |g volume:3 |g year:2018 |g elocationid:28 |g pages:1-11 |g extent:11 |a Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41541-018-0064-6 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41541-018-0064-6 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190423 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1078783403 |a Viebig, Nicola |m 1078783403:Viebig, Nicola |d 910000 |e 910000PV1078783403 |k 0/910000/ |p 10 | ||
| 998 | |g 1138953261 |a Havelange, Nicolas |m 1138953261:Havelange, Nicolas |d 910000 |e 910000PH1138953261 |k 0/910000/ |p 9 | ||
| 998 | |g 1081792701 |a Leroy, Odile |m 1081792701:Leroy, Odile |p 8 | ||
| 999 | |a KXP-PPN1663460027 |e 3452915360 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"17. July 2018"}],"id":{"doi":["10.1038/s41541-018-0064-6"],"eki":["1663460027"]},"name":{"displayForm":["Arnaud Chêne, Stéphane Gangnard, Célia Dechavanne, Sebastien Dechavanne, Anand Srivastava, Marilou Tétard, Sophia Hundt, Odile Leroy, Nicolas Havelange, Nicola K. Viebig, Benoît Gamain"]},"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"relHost":[{"language":["eng"],"recId":"87811839X","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine developmentnpj vaccines","note":["Gesehen am 30.01.2017"],"part":{"year":"2018","pages":"1-11","text":"3(2018), Artikel-ID 28, Seite 1-11","volume":"3","extent":"11"},"pubHistory":["1, article number 16001 (July 2016)-1, article number 16022 (December 2016) ; 2, article number 1 (January 2017)-"],"title":[{"title":"npj vaccines","title_sort":"npj vaccines"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["published in partnership with the Sealy Center for Vaccine Development"]},"id":{"zdb":["2882262-6"],"eki":["87811839X"],"issn":["2059-0105"]},"origin":[{"publisherPlace":"[London]","publisher":"Nature Publishing Group","dateIssuedDisp":"28 July 2016-"}]}],"title":[{"title":"Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development","title_sort":"Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development"}],"person":[{"roleDisplay":"VerfasserIn","display":"Chêne, Arnaud","role":"aut","family":"Chêne","given":"Arnaud"},{"roleDisplay":"VerfasserIn","display":"Leroy, Odile","role":"aut","family":"Leroy","given":"Odile"},{"roleDisplay":"VerfasserIn","display":"Havelange, Nicolas","role":"aut","family":"Havelange","given":"Nicolas"},{"display":"Viebig, Nicola","roleDisplay":"VerfasserIn","role":"aut","family":"Viebig","given":"Nicola"}],"note":["Gesehen am 23.04.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1663460027","language":["eng"]} | ||
| SRT | |a CHENEARNAUDOWNSELECT1720 | ||